Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Tocopherol pretreatment increases adriamycin bone marrow toxicity

D S Alberts, Y M Peng, T E Moon

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |October 1, 1978
    PubMed
    Summary

    Alpha-tocopherol and its acetate form potentiate adriamycin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Promising agents for chemoprevention of skin cancer.

    Current oncology (Toronto, Ont.)·2012
    Same author

    Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.

    Cancer causes & control : CCC·2012
    Same author

    Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.

    International journal of immunopathology and pharmacology·2011
    Same author

    Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

    Gynecologic oncology·2007
    Same author

    A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007

    Area of Science:

    • Oncology
    • Pharmacology
    • Biochemistry

    Background:

    • Alpha-tocopherol (vitamin E) is known to mitigate adriamycin's cardiotoxicity and lipid peroxidation.
    • Adriamycin is a potent chemotherapy agent with significant side effects.

    Purpose of the Study:

    • To investigate the combined effects of alpha-tocopherol and adriamycin on cancer treatment.
    • To assess the impact of alpha-tocopherol on adriamycin's efficacy and toxicity.

    Main Methods:

    • Mice models (normal and leukemic DBA/2) were used.
    • Alpha-tocopherol or alpha-tocopherol acetate was administered 24 hours before adriamycin.
    • Inhibition of mouse bone marrow (NCFU) and P388 leukemic (LCFU) stem cell growth was measured.

    Main Results:

    • Both free alpha-tocopherol and alpha-tocopherol acetate significantly increased adriamycin's toxicity to normal bone marrow stem cells (NCFU).
    • Alpha-tocopherol acetate did not significantly enhance adriamycin's inhibitory effect on leukemic stem cells (LCFU).
    • A p-value less than .02 indicated statistical significance for increased bone marrow toxicity.

    Conclusions:

    • Free alpha-tocopherol and alpha-tocopherol acetate may enhance adriamycin's toxicity to bone marrow.
    • This potentiation could impact the therapeutic window of adriamycin chemotherapy.
    • Further research is needed to clarify the clinical implications of these interactions.

    Related Experiment Videos